First Tracks Biotherapeutics, Inc. TRAX
—
34.42
(1.41)
(3.94%)
as of 25 Sep
- Market cap
- $1.3B
- P/E
- —
Follow TRAX
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+1 more quarter Free account |
— | 10.20 | 8.74 | 14.28 |
Net Debt/EBITDA |
0.00 | 0.00 | 5.44 | 4.86 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
— | — | — | 0.00 | |
Operating CF/Net income |
0.91 | — | 0.65 | 0.96 | |
Capex/Depreciation |
0.04 | — | (0.15) | (0.07) | |
Interest Coverage |
0.00 | — | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Free Cash Flow per Share |
(1.34) | — | 0.00 | (0.91) | |
Cash per Share |
0.00 | 0.00 | 0.00 | 4.80 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 4.82 | |
Interest Debt per Share |
0.00 | — | — | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 4.82 | |
Free Cash Flow |
(38.68) | — | (32.58) | (31.94) | |
Working Capital |
— | 285.38 | 256.29 | 165.30 | |
Capital Expenditures |
(0.04) | — | (0.02) | (0.02) | |
Net Current Asset Value |
0.00 | 273.35 | 256.29 | 163.40 | |
| Other line items | |||||
Quick Ratio |
— | 10.05 | 8.65 | 13.50 | |
Revenue per Share |
0.00 | — | — | 0.00 | |
Operating CF per Share |
(1.34) | — | 0.00 | (0.91) | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Average Assets |
— | — | — | 91.57 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | — | 0.00% | 0.00% |
Columns are period end dates